Status
Conditions
Treatments
About
The overall aim of the study is to investigate the effect of a new, non-pharmacological method that may alleviate the symptoms of narcolepsy and thereby lead to a reduction in the use of medications with potentially serious side effects in patients with this disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Lars Hyllienmark, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal